T1	Participants 112 159	patients with lymphoma and resolved hepatitis B
T2	Participants 294 341	patients with lymphoma and resolved hepatitis B
T4	Participants 780 800	Fifty-eight patients
T5	Participants 951 962	one patient
T6	Participants 1004 1018	seven patients
T7	Participants 1216 1229	control group
T8	Participants 1294 1307	Four patients
T9	Participants 1517 1530	control group
T3	Participants 376 437	ighty patients with CD20(+) lymphoma and resolved hepatitis B
